...
首页> 外文期刊>Laboratory investigation >Tumor-associated E-cadherin mutations do not induce Wnt target gene expression, but affect E-cadherin repressors
【24h】

Tumor-associated E-cadherin mutations do not induce Wnt target gene expression, but affect E-cadherin repressors

机译:肿瘤相关的E-钙粘蛋白突变不会诱导Wnt靶基因表达,但会影响E-钙粘蛋白阻遏物

获取原文
           

摘要

E-cadherin is a cell–cell adhesion molecule and tumor invasion suppressor gene that is frequently altered in human cancers. It interacts through its cytoplasmic domain with -catenin which in turn interacts with the Wnt (wingless) signaling pathway. We have compared the effects of different tumor-derived E-cadherin variants with those of normal E-cadherin on Wnt signaling and on genes involved in epithelial mesenchymal transition. We established an in-house cDNA microarray composed of 1105 different, sequence verified cDNA probes corresponding to 899 unique genes that represent the majority of genes known to be involved in cadherin-dependent cell adhesion and signaling ('Adhesion/Signaling Array'). The expression signatures of E-cadherin-negative MDA-MB-435S cancer cells transfected with E-cadherin variants (in frame deletions of exon 8 or 9, D8 or D9, respectively, or a point mutation in exon 8 (D370A)) were compared to that of wild-type E-cadherin (WT) transfected cells. From the differentially expressed genes, we selected 38 that we subsequently analyzed by quantitative real-time RT-PCR and/or Northern Blot. A total of 92% of these were confirmed as differentially expressed. Most of these genes encode proteins of the cytoskeleton, cadherins/integrins, oncogenes and matrix metalloproteases. No significant expression differences of genes downstream of the Wnt-pathway were found, except in E-cadherin D8 transfected cells where upregulation of three Tcf/Lef-transcribed genes was seen. One possible reason for the lack of expression differences of the Tcf/Lef-regulated genes is upregulation of SFRP1 and SFRP3; both of which are competitive inhibitors of the Wnt proteins. Interestingly, known E-cadherin transcriptional repressors, such as SLUG (SNAI2), SIP1 (ZEB2), TWIST1, SNAIL (SNAI1) and ZEB1 (TCF8), but not E12/E47 (TCF3), had a lack of upregulation in cells expressing mutated E-cadherin compared to WT. In conclusion, E-cadherin mutations have no influence on expression of genes involved in Wnt-signaling, but they may promote their own expression by blocking upregulation of E-cadherin repressors.
机译:E-cadherin是一种细胞间粘附分子和肿瘤侵袭抑制基因,在人类癌症中经常发生改变。它通过其胞质结构域与-catenin相互作用,后者又与Wnt(无翅)信号通路相互作用。我们已经比较了不同的肿瘤来源的E-钙粘蛋白变体与正常E-钙粘蛋白的变体对Wnt信号和上皮间质转化相关基因的影响。我们建立了一个由1105个不同的,经过序列验证的cDNA探针组成的内部cDNA微阵列,该探针对应于899个独特的基因,这些基因代表已知与钙黏着蛋白依赖性细胞粘附和信号传导有关的大多数基因(“粘附/信号传导阵列”)。转染E-cadherin变体的E-cadherin阴性MDA-MB-435S癌细胞的表达特征(分别在外显子8或9,D8或D9的框内缺失或外显子8的点突变(D370A))与野生型E-钙粘蛋白(WT)转染的细胞相比。从差异表达的基因中,我们选择了38个,随后通过定量实时RT-PCR和/或Northern Blot分析。其中总共92%被确认为差异表达。这些基因大多数编码细胞骨架蛋白,钙粘蛋白/整合素,癌基因和基质金属蛋白酶。除了在E-钙粘蛋白D8转染的细胞中观察到三个Tcf / Lef转录的基因上调外,未发现Wnt途径下游基因的显着表达差异。 Tcf / Lef调控基因缺乏表达差异的可能原因之一是SFRP1和SFRP3的上调。两者都是Wnt蛋白的竞争性抑制剂。有趣的是,已知的E-钙粘着蛋白转录阻遏物,例如SLUG(SNAI2),SIP1(ZEB2),TWIST1,SNAIL(SNAI1)和ZEB1(TCF8),但没有E12 / E47(TCF3),在表达细胞中缺乏上调与WT相比,突变的E-钙粘蛋白。总之,E-cadherin突变对参与Wnt信号转导的基因的表达没有影响,但是它们可能通过阻止E-cadherin阻遏物的上调来促进其自身表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号